Welcure Drugs & Pharmaceuticals P/E Ratio
Current P/E Ratio
0.97
Low Valuation
Very Low - Potentially undervalued or facing challenges
Welcure Drugs & Pharmaceuticals (WELCURE) P/E ratio is 0.97 (Low), EPS (TTM) ₹0.36, current price ₹0.26 on BSE — Very Low - Potentially undervalued or facing challenges. For live price, revenue and the complete fundamental profile, see Welcure Drugs & Pharmaceutical share price chart.
Current Valuation Metrics
P/E Ratio
0.97
Current Price
₹0.26
EPS (TTM)
₹0.36
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
49.3
Sector Median
29.34
Sector Rank
#1 of 193
Sector Percentile
0.5%
WELCURE P/E Ratio — Valuation Signal & Historical Context
Welcure Drugs & Pharmaceuticals P/E 0.97 — signal: Undervalued. Analyse Welcure Drugs & Pharmaceutical ownership structure to track promoter, FII and institutional holdings.
- Stock appears undervalued with PE of 0.97, suggesting potential buying opportunity
- Trading at discount to sector average PE of 49.3
WELCURE vs Healthcare Peers — P/E Ratio Comparison
Welcure Drugs & Pharmaceuticals P/E 0.97 vs Healthcare average 49.3, median 29.34 — range 2.86–869.57.
Sector Average
49.3
Sector Median
29.34
Lowest P/E
2.86
Highest P/E
869.57
Companies
193
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.39 | ₹7,561 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.04 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 6.85 | ₹20 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹28 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |